Navigation Links
Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations
Date:4/29/2011

ksi's experience includes nearly 25 years of diverse experience in health care and the biopharmaceutical industry, including leadership positions in marketing, sales and global strategic marketing.  He previously held positions at Centocor, Ortho Biotech, Bristol-Myers Squibb and Roche-Genentech.  

ABOUT SAVIENT PHARMACEUTICALS, INC.Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA® (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA and its uses from Duke University ("Duke") and Mountain View Pharmaceuticals, Inc. ("MVP").  Duke developed the recombinant uricase enzyme and MVP developed the PEGylation technology used in the manufacture of KRYSTEXXA. MVP and Duke have been granted U.S. and foreign patents disclosing and claiming the licensed technology and, in addition, Savient owns or co-owns U.S. and foreign patents and patent applications, which collectively form a broad portfolio of patents covering the composition, manufacture and methods of use and administration of KRYSTEXXA.  Savient also manufactures and supplies Oxandrin® (oxandrolone tablets, USP) CIII in the U.S.

FORWARD LOOKING STATEMENTS All statements other than statements of historical facts included in this press release are forward-looking statements that are subject to certain risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in such statements. These risks, trends and uncertainties are in some instances beyond our control. Words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," "will" and other similar expressions identify forward-looking statements, although not all forward-looking statements contain these identifying words. In particular,
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
7. Savient Provides Update on KRYSTEXXA(TM) BLA Resubmission Activities
8. Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
9. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
10. Savient Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
11. Savient Pharmaceuticals To Hold First Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today ... - FBR 1 st Annual Healthcare Conference ... on Wednesday, September 3 rd - Citi,s 9 ... on Thursday, September 4 th In ... of America Merrill Lynch Global Healthcare Conference at the Bank ...
(Date:8/20/2014)... Reportlinker.com announces that a new market ... The Impact of Healthcare Reform (PPACA) On ... http://www.reportlinker.com/p01618927/The-Impact-of-Healthcare-Reform-PPACA-On-the-US-IVD-Industry.html The "Patient Protection and ... that affects virtually every aspect of health care, ... take effect now. IVD manufacturers who have different ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com ... is available in its catalogue: ... Key Trends and Opportunities to 2017 ... Synopsis The report provides in depth ... Canadian personal accident and health insurance segment, ...
Breaking Medicine Technology:PTC Therapeutics to Participate at Upcoming Investor Conferences 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 3The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 4The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 5The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 6Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 2Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 3Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 4Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 5Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 6Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 7Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 8Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 9Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 10Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 11Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 12Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 13Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 14Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 15Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 16Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 17Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 18Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 19Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 20Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 21Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 22Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 23
... a specialty clinical stage pharmaceutical company focused on ... of the eye, today announced it has secured ... The funds will be used to complete a ... lead product, MC-1101.  Concurrently, MacuCLEAR has also entered ...
... BOSTON, Jan. 3, 2012  PAREXEL International Corporation (NASDAQ: ... of Fiscal Year 2012 on Monday, January 30, 2012 after ... available on PAREXEL,s website at www.PAREXEL.com and on ... PAREXEL will host a conference call and live webcast at ...
Cached Medicine Technology:MacuCLEAR, Inc. Raises More Than $1M in Financing and Enters into Strategic Pacific Rim Partnership 2PAREXEL Announces Date of Second Quarter Fiscal Year 2012 Earnings Release and Conference Call 2
(Date:8/21/2014)... Aug. 21, 2014 Individuals with schizophrenia often have ... themselves, and a new study from San Francisco State ... assessing the amount of effort required to complete tasks. ... week in the Journal of Abnormal Psychology , ... patients with schizophrenia and help those patients function normally ...
(Date:8/21/2014)... Entries are now open for the 2014 HREI ... totally dedicated to recognizing excellence in the areas of ... deadline is Oct. 17. , The awards are being ... only national magazine entirely devoted to covering healthcare real ... HREI Insights Awards program last year and it was ...
(Date:8/21/2014)... 21, 2014 Recently it came to ... company located in Massachusetts has made public claims on ... marijuana patient verification system in the Massachusetts cannabis industry. ... to our growing and compassionate industry we must set ... claims are inaccurate. , MarijuanaDoctors.com has actually been ...
(Date:8/21/2014)... Steven Reinberg HealthDay Reporter ... drug shows promise in treating respiratory syncytial virus (RSV), a ... are finally making major progress in being able to treat ... serious viral pneumonia, second only to influenza virus," said study ... University of Tennessee College of Medicine in Memphis. ...
(Date:8/21/2014)... by their self-interest, humans do not protest being ... in Georgia State University,s Brains and Behavior Program ... are less concerned than previously believed about the ... published in the journal Brain Connectivity . ... affected by their self-interest, indicating the interest humans ...
Breaking Medicine News(10 mins):Health News:Difficulty assessing effort drives motivation deficits in schizophrenia, study finds 2Health News:Entries Open for 2014 HREI Insights Awards™ 2Health News:Entries Open for 2014 HREI Insights Awards™ 3Health News:Entries Open for 2014 HREI Insights Awards™ 4Health News:MarijuanaDoctors.com Responds to Massachusetts Company's Claim 2Health News:New Drug May Fight Serious Respiratory Virus in Infants 2Health News:New Drug May Fight Serious Respiratory Virus in Infants 3Health News:Influenced by self-interest, humans less concerned about inequity to others 2Health News:Influenced by self-interest, humans less concerned about inequity to others 3
... incidence of new diseases and rise in infectious diseases is ... led to an imbalance in between natural reservoirs and human ... spread of new virus infections such as SARS, bird flu ... to antibiotics and other drugs due to indiscriminate use of ...
... under increased pressure from charities for making it possible to increase ... tamoxifen//. Women suffering from the early stages of the disease are ... for two years were to switch over to anastrozole, one of ... a period of two and a half years, according to the ...
... recipient has undergone a further graft on Friday, even ... in Lyons, France, received a second transplant of bone ... had been successful, doctors said. This is meant to ... ,The technique was developed by Prof Jean-Michel Dubernard, ...
... stroke, three leading killers in the U.S., all dropped in ... ,Also, Americans' life expectancy increased again in 2003, up ... in 1990. ,Life expectancy in the U.S. has ... including advances in medicine and sanitation, and declines in unhealthy ...
... mother Bernadette Mimura, belonging to Ingleby Barwick Ingleby Barwick who ... disease//. She had refused life-saving treatment as it involved making ... the unborn baby, by the doctors. ,Being a ... a mild form of chemotherapy treatment with the object of ...
... of regulations was established by The Society for ... were basically for the welfare of the patients// ... doctors and other staff members. All the cardiological ... care in the sterilization unit. ,These ...
Cached Medicine News:Health News:Face transplant woman has new graft 2Health News:US life expectancy climbs to a new high 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: